Hippo Pathway/TEAD Luciferase Reporter MCF7 Cell Line

Catalog #
60618
$2,570 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The TEAD Luciferase Reporter MCF7 cell line contains the firefly luciferase gene under the control of TEAD responsive elements stably integrated into the human breast cancer cell line MCF7. When the Hippo pathway is not stimulated, transcriptional coactivators YAP (Yes-associated protein) and TAZ (also known as WWTR1, WW domain containing transcription regulator 1) are localized in the nucleus and induce constitutive expression of the luciferase reporter. The cell line has been validated for the inhibition of the luciferase reporter by activators of the Hippo pathway, and for the activation of the luciferase reporter by inhibitors of the Hippo pathway.

Interested in screening and profiling activators of the Hippo pathway without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

This product has been cited 7 times.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
Hippo, Hippo signalling pathway, Hippo signalling cascade, Salvador-Warts-Hippo signalling pathway, SWH signalling pathway
Product Info
Storage and Usage
Citations7
Host Cell Line
MCF7 cells, human breast mammary gland cell line, epithelial cells, adherent
Species
Human
Supplied As
Each vial contains 2 x 106 cells in 1 ml of cell freezing medium (BPS Bioscience, #79796)
Materials Required But Not Supplied

Materials Required for Cell Culture

Name Ordering Information
Thaw Medium 1 BPS Bioscience #60187
Growth Medium 1B BPS Bioscience #79531
Insulin Solution from Bovine Pancreas Sigma-Aldrich #I0516

Materials Used in the Cellular Assay

Name Ordering Information
Thaw Medium 1 BPS Bioscience #60187
Insulin Solution from Bovine Pancreas Sigma-Aldrich #I0516
Okadaic acid (stock 10 mM in DMSO) BPS Bioscience #27047
H2O2  
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
96-well tissue culture-treated white clear-bottom assay plate  
Luminometer  
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

The Hippo cell signaling pathway regulates organ size and acts as a tumor suppressor by suppressing the transcription of genes controlled by transcription factor TEAD (Transcriptional enhancer factor TEF-1). The Hippo pathway is activated by high cell density and cellular stress to stop cell proliferation and induce apoptosis. Activation of this pathway triggers a kinase cascade in which MST (Macrophage-stimulating) kinases phosphorylate LATS (Large tumor suppressor) kinases, which then phosphorylate transcriptional co-activators YAP and TAZ. In unstimulated cells, dephosphorylated YAP and TAZ are localized in the nucleus and interact with TEAD transcriptional factors to induce cell cycle-promoting gene transcription. Upon stimulation of the Hippo pathway, newly phosphorylated YAP and TAZ are sequestered in the cytosol, and TEAD-dependent gene transcription is turned off. Dysfunction of the Hippo pathway is frequently detected in human cancer and correlates with cancer aggressiveness and poor prognosis.

References

1. Lamar JM et al. (2012) The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci U S A. 109(37):E2441-50. doi: 10.1073/pnas.1212021109.
2. Hata Y et al. (2013) Okadaic Acid: a tool to study the hippo pathway. Mar Drugs. 11(3):896-902. doi: 10.3390/md11030896.
3. Bao Y et al. (2011) A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J Biochem. 150(2):199-208.